Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arcutis Biotherapeutics (ARQT) Accumulated Depreciation & Amortization (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 5 years of Accumulated Depreciation & Amortization data on record, last reported at $2.6 million in Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 33.26% year-over-year to $2.6 million; the TTM value through Dec 2024 reached $2.6 million, up 33.26%, while the annual FY2024 figure was $2.6 million, 33.26% up from the prior year.
  • Accumulated Depreciation & Amortization reached $2.6 million in Q4 2024 per ARQT's latest filing, up from $1.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.6 million in Q4 2024 and bottomed at $78000.0 in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $1.1 million, with a median of $994500.0 recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 582.05% in 2021, then soared 33.26% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $78000.0 in 2020, then soared by 582.05% to $532000.0 in 2021, then surged by 116.73% to $1.2 million in 2022, then surged by 66.87% to $1.9 million in 2023, then skyrocketed by 33.26% to $2.6 million in 2024.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $2.6 million in Q4 2024, $1.9 million in Q4 2023, and $1.3 million in Q1 2023.